244 related articles for article (PubMed ID: 26604137)
21. Whole Exome Sequencing in Atrial Fibrillation.
Lubitz SA; Brody JA; Bihlmeyer NA; Roselli C; Weng LC; Christophersen IE; Alonso A; Boerwinkle E; Gibbs RA; Bis JC; ; Cupples LA; Mohler PJ; Nickerson DA; Muzny D; Perez MV; Psaty BM; Soliman EZ; Sotoodehnia N; Lunetta KL; Benjamin EJ; Heckbert SR; Arking DE; Ellinor PT; Lin H
PLoS Genet; 2016 Sep; 12(9):e1006284. PubMed ID: 27589061
[TBL] [Abstract][Full Text] [Related]
22. Replication of prostate cancer risk loci in a Japanese case-control association study.
Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
[TBL] [Abstract][Full Text] [Related]
23. Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men.
Tonon L; Fromont G; Boyault S; Thomas E; Ferrari A; Sertier AS; Kielbassa J; Le Texier V; Kamoun A; Elarouci N; Irani J; Multigner L; Gut IG; Gut M; Blanchet P; De Reynies A; Cancel-Tassin G; Viari A; Cussenot O
Eur Urol; 2019 Jan; 75(1):11-15. PubMed ID: 30245085
[TBL] [Abstract][Full Text] [Related]
24. Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer.
Nicolas E; Arora S; Zhou Y; Serebriiskii IG; Andrake MD; Handorf ED; Bodian DL; Vockley JG; Dunbrack RL; Ross EA; Egleston BL; Hall MJ; Golemis EA; Giri VN; Daly MB
Oncotarget; 2015 Nov; 6(37):39614-33. PubMed ID: 26485759
[TBL] [Abstract][Full Text] [Related]
25. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
[TBL] [Abstract][Full Text] [Related]
26. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.
Kittles RA; Baffoe-Bonnie AB; Moses TY; Robbins CM; Ahaghotu C; Huusko P; Pettaway C; Vijayakumar S; Bennett J; Hoke G; Mason T; Weinrich S; Trent JM; Collins FS; Mousses S; Bailey-Wilson J; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD
J Med Genet; 2006 Jun; 43(6):507-11. PubMed ID: 16155194
[TBL] [Abstract][Full Text] [Related]
27. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
[TBL] [Abstract][Full Text] [Related]
28. A common variant associated with prostate cancer in European and African populations.
Amundadottir LT; Sulem P; Gudmundsson J; Helgason A; Baker A; Agnarsson BA; Sigurdsson A; Benediktsdottir KR; Cazier JB; Sainz J; Jakobsdottir M; Kostic J; Magnusdottir DN; Ghosh S; Agnarsson K; Birgisdottir B; Le Roux L; Olafsdottir A; Blondal T; Andresdottir M; Gretarsdottir OS; Bergthorsson JT; Gudbjartsson D; Gylfason A; Thorleifsson G; Manolescu A; Kristjansson K; Geirsson G; Isaksson H; Douglas J; Johansson JE; Bälter K; Wiklund F; Montie JE; Yu X; Suarez BK; Ober C; Cooney KA; Gronberg H; Catalona WJ; Einarsson GV; Barkardottir RB; Gulcher JR; Kong A; Thorsteinsdottir U; Stefansson K
Nat Genet; 2006 Jun; 38(6):652-8. PubMed ID: 16682969
[TBL] [Abstract][Full Text] [Related]
29. Fine-mapping of IL16 gene and prostate cancer risk in African Americans.
Batai K; Shah E; Murphy AB; Newsome J; Ruden M; Ahaghotu C; Kittles RA
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2059-68. PubMed ID: 22923025
[TBL] [Abstract][Full Text] [Related]
30. Rare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke: The NHLBI Exome Sequence Project.
Auer PL; Nalls M; Meschia JF; Worrall BB; Longstreth WT; Seshadri S; Kooperberg C; Burger KM; Carlson CS; Carty CL; Chen WM; Cupples LA; DeStefano AL; Fornage M; Hardy J; Hsu L; Jackson RD; Jarvik GP; Kim DS; Lakshminarayan K; Lange LA; Manichaikul A; Quinlan AR; Singleton AB; Thornton TA; Nickerson DA; Peters U; Rich SS;
JAMA Neurol; 2015 Jul; 72(7):781-8. PubMed ID: 25961151
[TBL] [Abstract][Full Text] [Related]
31. Exome sequencing in patients with chronic central serous chorioretinopathy.
Schellevis RL; Breukink MB; Gilissen C; Boon CJF; Hoyng CB; de Jong EK; den Hollander AI
Sci Rep; 2019 Apr; 9(1):6598. PubMed ID: 31036833
[TBL] [Abstract][Full Text] [Related]
32. Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies).
Cancel-Tassin G; Romana M; Gaffory C; Blanchet P; Cussenot O; Multigner L
Asian J Androl; 2015; 17(1):117-9. PubMed ID: 25130587
[TBL] [Abstract][Full Text] [Related]
33. Discovery of rare ancestry-specific variants in the fetal genome that confer risk of preterm premature rupture of membranes (PPROM) and preterm birth.
Modi BP; Parikh HI; Teves ME; Kulkarni R; Liyu J; Romero R; York TP; Strauss JF
BMC Med Genet; 2018 Oct; 19(1):181. PubMed ID: 30290772
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.
Plym A; Penney KL; Kalia S; Kraft P; Conti DV; Haiman C; Mucci LA; Kibel AS
J Natl Cancer Inst; 2022 May; 114(5):771-774. PubMed ID: 33792693
[TBL] [Abstract][Full Text] [Related]
35. Replication and heritability of prostate cancer risk variants: impact of population-specific factors.
Virlogeux V; Graff RE; Hoffmann TJ; Witte JS
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):938-43. PubMed ID: 25809866
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of mitochondrial genomic variation and associated clinical presentation of prostate cancer in South African men.
McCrow JP; Petersen DC; Louw M; Chan EK; Harmeyer K; Vecchiarelli S; Lyons RJ; Bornman MS; Hayes VM
Prostate; 2016 Mar; 76(4):349-58. PubMed ID: 26660354
[TBL] [Abstract][Full Text] [Related]
37. Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes.
Karyadi DM; Geybels MS; Karlins E; Decker B; McIntosh L; Hutchinson A; Kolb S; McDonnell SK; Hicks B; Middha S; FitzGerald LM; DeRycke MS; Yeager M; Schaid DJ; Chanock SJ; Thibodeau SN; Berndt SI; Stanford JL; Ostrander EA
Oncotarget; 2017 Jan; 8(1):1495-1507. PubMed ID: 27902461
[TBL] [Abstract][Full Text] [Related]
38. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Dadaev T; Saunders EJ; Newcombe PJ; Anokian E; Leongamornlert DA; Brook MN; Cieza-Borrella C; Mijuskovic M; Wakerell S; Olama AAA; Schumacher FR; Berndt SI; Benlloch S; Ahmed M; Goh C; Sheng X; Zhang Z; Muir K; Govindasami K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman P; Thompson IM; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger G; Gronberg H; Aly M; Nordström T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West C; Dunning AM; Burnet N; Mucci L; Giovannucci E; Andriole G; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein B; Kerns S; Ostrer H; Lu YJ; Zhang HW; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gómez-Caamaño A; Fachal L; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castaño-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin HY; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weisher M; Bisbjerg R; Røder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo SH; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Slavov C; Mitev V; Parliament M; Singhal S; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw KT; Cannon-Albright L; Pandha H; Michael A; Kierzek A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Kraft P; ; Freedman M; Wiklund F; Chanock S; Henderson BE; Easton DF; Haiman CA; Eeles RA; Conti DV; Kote-Jarai Z
Nat Commun; 2018 Jun; 9(1):2256. PubMed ID: 29892050
[TBL] [Abstract][Full Text] [Related]
39. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.
Emami NC; Cavazos TB; Rashkin SR; Cario CL; Graff RE; Tai CG; Mefford JA; Kachuri L; Wan E; Wong S; Aaronson D; Presti J; Habel LA; Shan J; Ranatunga DK; Chao CR; Ghai NR; Jorgenson E; Sakoda LC; Kvale MN; Kwok PY; Schaefer C; Risch N; Hoffmann TJ; Van Den Eeden SK; Witte JS
Cancer Res; 2021 Apr; 81(7):1695-1703. PubMed ID: 33293427
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer genetic risk and associated aggressive disease in men of African ancestry.
Soh PXY; Mmekwa N; Petersen DC; Gheybi K; van Zyl S; Jiang J; Patrick SM; Campbell R; Jaratlerdseri W; Mutambirwa SBA; Bornman MSR; Hayes VM
Nat Commun; 2023 Dec; 14(1):8037. PubMed ID: 38052806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
